REVELATION BIOSCIENCES INC (REVB)
US76135L5075 - Common Stock
Which stocks have an unusual volume on Tuesday?
Let's have a look at what is happening on the US markets on Tuesday. Below you can find the stocks with an unusual volume in today's session.
Revelation Biosciences, Inc. Completes the GMP Manufacture of Gemini Clinical Drug Supply
These stocks have an unusual volume in today's session
Let's have a look at what is happening on the US markets on Monday. Below you can find the stocks with an unusual volume in today's session.
Monday's pre-market session: top gainers and losers
What's going on in Monday's pre-market session
Friday's after hours session: top gainers and losers
Curious about the stocks that are showing activity after the closing bell on Friday?
Revelation Biosciences, Inc. Announces Financial Results for the Three and Nine Months Ended September 30, 2024
Revelation Biosciences’ Gemini Induces Dose Dependent Significant Increases in IL-10
Revelation Biosciences Inc. Announces Exercise of Warrants for $3.8 Million in Gross Proceeds
REVB Stock Earnings: Revelation Biosciences Misses EPS for Q2 2024
REVB stock results show that Revelation Biosciences missed analyst estimates for earnings per share the second quarter of 2024.
REVB Stock Earnings: Revelation Biosciences Misses EPS for Q2 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Revelation Biosciences (NASDAQ:REVB) just reported results for the second quart...
Revelation Biosciences, Inc. Announces Financial Results for the Three and Six Months Ended June 30, 2024
Revelation Biosciences Announces Phase 1 Clinical Study of Gemini Met the Primary Safety Endpoint and Showed Statistically Significant Biomarker Activity
Revelation Biosciences Has Completed Dosing of its First in Human Phase 1 Clinical Study of Gemini
REVB Stock Earnings: Revelation Biosciences Misses EPS for Q1 2024
REVB stock results show that Revelation Biosciences missed analyst estimates for earnings per share the first quarter of 2024.
REVB Stock Earnings: Revelation Biosciences Misses EPS for Q1 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Revelation Biosciences (NASDAQ:REVB) just reported results for the first quarte...
Revelation Biosciences, Inc. Announces Financial Results for the Three Months Ended March 31, 2024
REVB Stock Earnings: Revelation Biosciences Beats EPS for Q4 2023
REVB stock results show that Revelation Biosciences beat analyst estimates for earnings per share the fourth quarter of 2023.
REVB Stock Earnings: Revelation Biosciences Beats EPS for Q4 2023
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Revelation Biosciences (NASDAQ:REVB) just reported results for the fourth quart...
Revelation Biosciences, Inc. Announces Financial Results for the Three and Twelve Months Ended December 31, 2023
Revelation Biosciences Inc. Gives Oral Presentation at Advances in Critical Care Nephrology (AKI & CRRT 2024)
Revelation Biosciences Inc. to Participate in a Virtual Fireside Chat at the 36th Annual Roth Conference
Revelation Biosciences Inc. Announces Commencement of First in Human Phase 1 Clinical Study of Gemini
